US Patent Application No: 2010/0255,007

Number of patents in Portfolio can not be more than 2000

THERAPEUTIC AGENTS FOR GRAFT-VERSUS-HOST DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

ALSO PUBLISHED AS: 8529895

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel therapeutic agent for graft-versus-host disease (GVHD).A therapeutic agent for graft-versus-host disease (GVHD), which comprises an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CHUGAI SEIYAKU KABUSHIKI KAISHATOKYO356

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mihara, Masahiko Gotenba, JP 15 184
Moriya, Yoichiro Gotenba, JP 5 104

Cited Art Landscape

Patent Info (Count) # Cites Year
 
ONO PHARMACEUTICAL CO., LTD. (1)
* 2005/0119,305 Il-6 production inhibitors 34 2003
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
* 2004/0071,666 Compositions and methods related to graft-versus-host disease 3 2003
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
CHUGAI SEIYAKU KABUSHIKI KAISHA (4)
8,840,884 Antibody-containing solution pharmaceuticals 0 2003
8,398,980 Subtypes of humanized antibody against interleuken-6 receptor 2 2005
8,709,409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate 0 2009
8,734,800 Subtypes of humanized antibody against interleukin-6 receptor 0 2012
 
F. HOFFMANN-LA ROCHE AG (1)
8,568,720 High concentration antibody-containing liquid formulation 0 2008
 
HOFFMANN-LA ROCHE INC. (1)
8,580,264 Subcutaneously administered anti-IL-6 receptor antibody 0 2011
* Cited By Examiner